(-)-Stepholidine acts as a D1 partial agonist on firing activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine-lesioned rats

Life Sciences

Volumn 59, Issue 4, 1996, Pages 299-306

  Sun, Bao Cun ^a,b   Zhang, Xue Xiang ^a   Jin, Guo Zhang ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b The State University of New Jersey   (United States)

Author keywords

6 Hydroxydopamine; Dopamine receptors; Electrophysiology; Reserpine; Stepholidine; Substantia nigra

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; HALOPERIDOL; STEPHOLIDINE; BERBERINE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; OXIDOPAMINE; RESERPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCLING BEHAVIOR; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; ELECTROPHYSIOLOGY; LOCOMOTION; NERVE CONDUCTION; NONHUMAN; RAT; RETICULAR FORMATION; STEREOTYPY; SUBSTANTIA NIGRA; ANIMAL; CELL MEMBRANE POTENTIAL; COMPARATIVE STUDY; DRUG POTENTIATION; MALE; METHODOLOGY; MICROELECTRODE; NERVE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; APOMORPHINE; BERBERINE; DOPAMINE AGONISTS; ELECTROPHYSIOLOGY; HALOPERIDOL; MALE; MEMBRANE POTENTIALS; MICROELECTRODES; NEURONS; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RESERPINE; SUBSTANTIA NIGRA;

EID: 0029664819     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00298-6     Document Type: Article

References (19)

1. S.X. XU, L.P. YU, Y.R. HAN, Y. CHEN, G.Z. JIN, Acta Pharmacol. Sin. 10 104-110 (1989).
2. Z.D. ZHANG, G.Z. JIN, S.X. XU, L.P. YU, Y. CHEN, F.Y. JIANG, Y.R. ZHANG, Acta Pharmacol. Sin. 7 522-526 (1986).
3. G.Z. JIN, B.C. SUN, Prog. Natural Sci. 5 55-63. (1995).
4. L.J. CHEN, X. GUO, Q.M. WANG, G.Z. JIN, Acta Pharmacol. Sin. 13 442-445 (1992).
5. K.X. HUANG, B.C. SUN, F.G. GONON, G.Z. JIN, Acta Pharmacol. Sin. 12 32-36 (1991).
6. K.X. HUANG, G.Z. JIN, Sci. Sin. [B] 7 738-743 (1991).
7. B.C. SUN, G.Z. JIN, Acta Pharmacol. Sin. 13 395-399 (1992).
8. K.X. HUANG, B.C. SUN, G.Z. JIN, Acta Pharmacol. Sin. 13 17-22 (1992).
9. G.Z. JIN, K.X. HUANG, B.C. SUN, Neurochem. Int. 20 (suppl) 175s-178s (1992).
10. Z.J. DONG, L.J.CHEN, G.Z. JIN, I. CREESE, Biochem. Pharmacol. (in press).
11. K.X. HUANG, J.R. WALTERS, J. Pharmacol. Exp. Ther. 260 409-416 (1992).
12. B.C. SUN, G.Z. JIN, Biol. Signals 1 331-338 (1992).
13. B.C. SUN, K. X. HUANG, G.Z. JIN, Eur. J. Pharmacol. 231 331-338 (1993).
14. D.M. YUREK, S.B. HIPKENS, Brain Res. 639 329-332 (1994).
15. U. UNGERSTEDT, G. W. ARBUTHNOTT, Brain Res. 24 485-493 (1970).
16. B.L. WASZCZAK, E.K. LEE, T. FERRARO, T.A. HARE, J.R. WALTERS, Brain Res. 306 307-315 (1984).
17. G. PAXINOS, C. WATSON, The rat brain in stereotaxic coordinates, Academic Press, New York (1982).
18. J. ARNT, Eur. J. Pharmacol. 113 79-88 (1985).
19. J. ARNT, Life Sci. 37 717-723 (1985).